{"id":34184,"date":"2025-05-27T11:19:21","date_gmt":"2025-05-27T03:19:21","guid":{"rendered":"https:\/\/flcube.com\/?p=34184"},"modified":"2025-05-27T11:19:22","modified_gmt":"2025-05-27T03:19:22","slug":"salubris-pharma-inks-licensing-deal-for-gowells-gw906-in-greater-china","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=34184","title":{"rendered":"Salubris Pharma Inks Licensing Deal for Gowell&#8217;s GW906 in Greater China"},"content":{"rendered":"\n<p>China&#8217;s Shenzhen Salubris Pharmaceuticals Co., Ltd (<a href=\"https:\/\/www.google.com\/finance\/quote\/002294:SHE\">SHE: 002294<\/a>) announced a licensing agreement with compatriot firm Chengdu Gowell Biopharmaceutical Co., Ltd., securing comprehensive rights to the investigational drug GW906. This includes research and development, regulatory filing, manufacturing, and commercialization across mainland China, Hong Kong, Macau, and Taiwan.<\/p>\n\n\n\n<p><strong>Deal Financials<\/strong><br>Under the terms of the agreement, Salubris Pharma will make an upfront payment to Gowell Bio of up to RMB 180 million (USD 25 million). Additionally, Salubris is committed to a marketing milestone payment of up to RMB 370 million (USD 51.5 million), along with royalties based on annual sales.<\/p>\n\n\n\n<p><strong>GW906 siRNA Drug<\/strong><br>GW906 is a small interfering RNA (siRNA) drug targeting angiotensinogen (AGT) and is currently undergoing Phase I studies for primary hypertension. Administered via intermittent subcutaneous injection, GW906 has shown promising efficacy and safety profiles in preclinical trials.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u4fe1\u7acb\u6cf0\uff1a\u5173\u4e8e\u83b7\u5f97AGT-siRNA\u836f\u7269GW906\u72ec\u5bb6\u8bb8\u53ef\u6743\u76ca\u7684\u516c\u544a.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u4fe1\u7acb\u6cf0\uff1a\u5173\u4e8e\u83b7\u5f97AGT-siRNA\u836f\u7269GW906\u72ec\u5bb6\u8bb8\u53ef\u6743\u76ca\u7684\u516c\u544a.\"><\/object><a id=\"wp-block-file--media-5594c7a9-cc17-4d03-81d6-5b60a7630b2d\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u4fe1\u7acb\u6cf0\uff1a\u5173\u4e8e\u83b7\u5f97AGT-siRNA\u836f\u7269GW906\u72ec\u5bb6\u8bb8\u53ef\u6743\u76ca\u7684\u516c\u544a.pdf\">\u4fe1\u7acb\u6cf0\uff1a\u5173\u4e8e\u83b7\u5f97AGT-siRNA\u836f\u7269GW906\u72ec\u5bb6\u8bb8\u53ef\u6743\u76ca\u7684\u516c\u544a<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u4fe1\u7acb\u6cf0\uff1a\u5173\u4e8e\u83b7\u5f97AGT-siRNA\u836f\u7269GW906\u72ec\u5bb6\u8bb8\u53ef\u6743\u76ca\u7684\u516c\u544a.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-5594c7a9-cc17-4d03-81d6-5b60a7630b2d\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>China&#8217;s Shenzhen Salubris Pharmaceuticals Co., Ltd (SHE: 002294) announced a licensing agreement with compatriot firm&#8230;<\/p>\n","protected":false},"author":1,"featured_media":34186,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[2513,64,335,1167],"class_list":["post-34184","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-gowell-pharmaceutical","tag-rnai-aso","tag-salubris-pharmaceuticals","tag-she-002294"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Salubris Pharma Inks Licensing Deal for Gowell&#039;s GW906 in Greater China - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China&#039;s Shenzhen Salubris Pharmaceuticals Co., Ltd (SHE: 002294) announced a licensing agreement with compatriot firm Chengdu Gowell Biopharmaceutical Co., Ltd., securing comprehensive rights to the investigational drug GW906. This includes research and development, regulatory filing, manufacturing, and commercialization across mainland China, Hong Kong, Macau, and Taiwan.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=34184\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Salubris Pharma Inks Licensing Deal for Gowell&#039;s GW906 in Greater China\" \/>\n<meta property=\"og:description\" content=\"China&#039;s Shenzhen Salubris Pharmaceuticals Co., Ltd (SHE: 002294) announced a licensing agreement with compatriot firm Chengdu Gowell Biopharmaceutical Co., Ltd., securing comprehensive rights to the investigational drug GW906. This includes research and development, regulatory filing, manufacturing, and commercialization across mainland China, Hong Kong, Macau, and Taiwan.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=34184\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-27T03:19:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-27T03:19:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2701.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34184#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34184\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Salubris Pharma Inks Licensing Deal for Gowell&#8217;s GW906 in Greater China\",\"datePublished\":\"2025-05-27T03:19:21+00:00\",\"dateModified\":\"2025-05-27T03:19:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34184\"},\"wordCount\":153,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34184#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2701.webp\",\"keywords\":[\"Gowell Pharmaceutical\",\"RNAi \\\/ ASO\",\"Salubris Pharmaceuticals\",\"SHE: 002294\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34184#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34184\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=34184\",\"name\":\"Salubris Pharma Inks Licensing Deal for Gowell's GW906 in Greater China - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34184#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34184#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2701.webp\",\"datePublished\":\"2025-05-27T03:19:21+00:00\",\"dateModified\":\"2025-05-27T03:19:22+00:00\",\"description\":\"China's Shenzhen Salubris Pharmaceuticals Co., Ltd (SHE: 002294) announced a licensing agreement with compatriot firm Chengdu Gowell Biopharmaceutical Co., Ltd., securing comprehensive rights to the investigational drug GW906. This includes research and development, regulatory filing, manufacturing, and commercialization across mainland China, Hong Kong, Macau, and Taiwan.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34184#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34184\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34184#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2701.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2701.webp\",\"width\":1080,\"height\":608,\"caption\":\"Salubris Pharma Inks Licensing Deal for Gowell's GW906 in Greater China\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34184#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Salubris Pharma Inks Licensing Deal for Gowell&#8217;s GW906 in Greater China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Salubris Pharma Inks Licensing Deal for Gowell's GW906 in Greater China - Insight, China&#039;s Pharmaceutical Industry","description":"China's Shenzhen Salubris Pharmaceuticals Co., Ltd (SHE: 002294) announced a licensing agreement with compatriot firm Chengdu Gowell Biopharmaceutical Co., Ltd., securing comprehensive rights to the investigational drug GW906. This includes research and development, regulatory filing, manufacturing, and commercialization across mainland China, Hong Kong, Macau, and Taiwan.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=34184","og_locale":"en_US","og_type":"article","og_title":"Salubris Pharma Inks Licensing Deal for Gowell's GW906 in Greater China","og_description":"China's Shenzhen Salubris Pharmaceuticals Co., Ltd (SHE: 002294) announced a licensing agreement with compatriot firm Chengdu Gowell Biopharmaceutical Co., Ltd., securing comprehensive rights to the investigational drug GW906. This includes research and development, regulatory filing, manufacturing, and commercialization across mainland China, Hong Kong, Macau, and Taiwan.","og_url":"https:\/\/flcube.com\/?p=34184","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-05-27T03:19:21+00:00","article_modified_time":"2025-05-27T03:19:22+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2701.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=34184#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=34184"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Salubris Pharma Inks Licensing Deal for Gowell&#8217;s GW906 in Greater China","datePublished":"2025-05-27T03:19:21+00:00","dateModified":"2025-05-27T03:19:22+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=34184"},"wordCount":153,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=34184#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2701.webp","keywords":["Gowell Pharmaceutical","RNAi \/ ASO","Salubris Pharmaceuticals","SHE: 002294"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=34184#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=34184","url":"https:\/\/flcube.com\/?p=34184","name":"Salubris Pharma Inks Licensing Deal for Gowell's GW906 in Greater China - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=34184#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=34184#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2701.webp","datePublished":"2025-05-27T03:19:21+00:00","dateModified":"2025-05-27T03:19:22+00:00","description":"China's Shenzhen Salubris Pharmaceuticals Co., Ltd (SHE: 002294) announced a licensing agreement with compatriot firm Chengdu Gowell Biopharmaceutical Co., Ltd., securing comprehensive rights to the investigational drug GW906. This includes research and development, regulatory filing, manufacturing, and commercialization across mainland China, Hong Kong, Macau, and Taiwan.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=34184#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=34184"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=34184#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2701.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2701.webp","width":1080,"height":608,"caption":"Salubris Pharma Inks Licensing Deal for Gowell's GW906 in Greater China"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=34184#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Salubris Pharma Inks Licensing Deal for Gowell&#8217;s GW906 in Greater China"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2701.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=34184"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34184\/revisions"}],"predecessor-version":[{"id":34187,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34184\/revisions\/34187"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/34186"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=34184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=34184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=34184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}